市場調查報告書
商品編碼
1150465
全球蛋白酵素市場規模,份額,行業趨勢分析報告,按應用(肥皂/洗滌劑,食品/飲料,動物飼料,製藥),來源(微生物,動物,植物),區域展望/預測2022-2028Global Protease Market Size, Share & Industry Trends Analysis Report By Application (Soap & Detergents, Food & Beverages, Animal Feed, Pharmaceuticals), By Source (Microbes, Animals, and Plants), By Regional Outlook and Forecast, 2022 - 2028 |
蛋白酵素的全球市場規模預計將在 2028 年達到 50 億美元,在預測期內以 5.5% 的複合年增長率增長。
□鍵的水解是蛋白酵素有效執行的代表性化學反應。有些蛋白酵素的反應與大多數蛋白水解酵素略有不同,它們會破壞天然存在的氨基酸間□鍵。因此,一大類稱為DUBs的酵素水解泛素和泛素-蛋白複合物的異□鍵,谷氨酸水解酵素和谷氨酸羧□酵素靶向-谷氨酸鍵,谷氨□轉移酵素轉移和轉移□鍵。裂解和分子內自蛋白酵素也將具有生成□的能力債券,尤其是在某些情況下。
由於蛋白酵素具有抗癌、抗菌和抗炎等治療功效,它們越來越多地被製藥行業使用,預計在預測期內它們的需求將顯著增長,從而推動全球蛋白酵素市場的發展。預計將有利於用於慢性疼痛、心血管疾病和胃腸道疾病的藥物是使用蛋白酵素製造的。
COVID-19 影響分析
為減少 COVID-19 通過食品傳播,世界衛生組織 (WHO) 發布了指南以確保食品衛生和食品安全實踐。我們相信這些發展將增加對清潔標籤蛋白酵素產品的需求。隨著全球經濟復甦,人均收入增加和人們採用更健康的生活方式,預計該市場在預測期內也將增長。
市場增長因素
藥物和治療應用的增加
蛋白酵素具有許多益處,例如提高免疫力、預防炎症性腸病、治療燒傷和胃潰瘍,因此醫療保健領域的發展有望對蛋白酵素市場產生有利影響。然而,蛋白酵素市場的很大一部分由飼料等其他領域組成,其中蛋白酵素用於提高飼料的營養和消化率以及維持動物的內臟健康。
消費者消費意識增強
消費者對帶有清潔標籤和天然成分的產品的要求越來越高。由於健康意識的增強,蛋白酵素也越來越受歡迎。慢性病和流行病的流行鼓勵我們健康飲食,以保護自己免受許多致命疾病的侵害。
市場製約因素
蛋白酵素風險和潛在副作用
蛋白水解酵素通常被認為是無害的。但是,它可能會對某些人產生不利影響。可能會出現噁心、腹瀉和嘔吐等胃腸道症狀,尤其是大量攝入時。大量富含蛋白水解酵素的水果也會刺激胃,但補充劑更有可能刺激胃。也可能出現過敏症狀。
來源觀點
蛋白酵素市場按來源分為植物、動物和微生物。植物部分在 2021 年佔據了蛋白酵素市場的重要收入份額。植物來源的蛋白酵素類別包括木瓜蛋白酵素和菠蘿蛋白酵素。氣候、活力、培養、條件和延伸提取程序等因素也對植物作為蛋白酵素來源的使用產生重大影響。因此,預計蛋白酵素市場在預測期內將在該細分市場中增長。
應用展望
蛋白酵素市場按應用細分為食品和飲料、藥品、動物飼料、肥皂和洗滌劑等。到 2021 年,肥皂和洗滌劑部門將在蛋白酵素市場中佔據最大的收入份額。蛋白酵素的去污能力使其可用於洗滌劑製造。隨著消費者越來越注重衛生和清潔,對肥皂和洗滌劑的需求預計會增加。
區域展望
按區域劃分的蛋白酵素市場分析分為四個區域:北美、歐洲、亞太地區和 LAMEA。北美地區將在 2021 年以最大的收入份額引領蛋白酵素市場。對植物和動物蛋白酵素的需求不斷增長正在推動該地區蛋白酵素市場的擴張。對蛋白酵素的需求進一步源於各種食品功能、洗衣的重要性日益增加、對嬰兒配方奶粉的需求不斷增長以及肉類產品的消費和生產不斷增長。
The Global Protease Market size is expected to reach $5 billion by 2028, rising at a market growth of 5.5% CAGR during the forecast period.
An enzyme termed a protease, also known as a peptidase or proteinase, catalyzes, proteolysis, which results in the breakdown of proteins into smaller polypeptides or single amino acids and promotes the production of new protein products. They achieve this by using hydrolysis, a mechanism in which water breaks bonds, to cleave the peptide bonds found in proteins.
Protein digestion after ingestion, protein catabolism (the breakdown of aged proteins), and cell signaling are a few of the biological processes that proteases involved. Proteolysis would occur very slowly, requiring hundreds of years if there were no functional accelerants. All living forms and viruses have proteases. Distinct classes of protease can carry out the same reaction by entirely different catalytic processes as a result of their own numerous independent evolutionary cycles.
The hydrolysis of peptide bonds is a typical chemical reaction that is effectively carried out by proteases. There are several proteases that carry out slightly different reactions from the majority of proteolytic enzymes, which break down -peptide bonds between naturally existing amino acids. Thus, a large class of enzymes called DUBs can hydrolyze isopeptide bonds in ubiquitin and ubiquitin-such as protein conjugates; glutamyl hydrolase and glutamate carboxypeptidase target -glutamyl bonds; glutamyl transferase transfer and cleave peptide bonds; and intramolecular autoproteases such as notably, and under some circumstances, proteases are also capable of producing peptide bonds.
The pharmaceutical industry's increasing use of proteases for their therapeutic advantages, like anticancer, antibacterial, and anti-inflammation, is likely to result in a large increase in demand for them over the forecast period, which will favor the market for proteases globally. Drugs for the treatment of chronic pain, cardiovascular illnesses, and digestive issues are made using proteases.
COVID-19 Impact Analysis
To reduce COVID-19 transmission through food, the World Health Organization (WHO) has published guidelines for ensuring food hygiene and food safety practices. The demand for protease products with clean labels will rise as a result of these developments. The market will grow over the projected period as a result of the worldwide economy's recovery, which will also result in an increase in per capita income and the adoption of healthier lifestyles.
Market Growth Factors
Increasing Drug And Therapeutic Applications
Because of the many advantages proteases offer, like boosting the immune system, preventing inflammatory bowel diseases, and treating burns, and stomach ulcers, the rise of the healthcare sector will have a beneficial impact on the protease market. However, a large component of the protease market is made up of other sectors, like animal feed, where protease is employed to enhance the nutritional or digestive qualities of fodder and preserve the health of animal guts.
Rising Consumer Awareness Regarding What They Are Consuming
Consumer demand for goods with clean labels as well as natural ingredients is rising. The popularity of protease among those who are concerned about their health has increased as people become more conscious of the necessity to live a healthy lifestyle. The prevalence of chronic illnesses and pandemic situations are encouraging people to adopt healthy eating practices in order to protect themselves against a number of deadly ailments.
Market Restraining Factors
Risks And Possible Side Effects Of Protease
Proteolytic enzymes are generally regarded as harmless. However, some people may experience negative effects. It's conceivable, especially if someone takes very large quantities, that may develop digestive problems like nausea, diarrhea, and vomiting. Large amounts of fruits rich in proteolytic enzymes could also irritate the stomach, though supplements are much more likely to do so. Symptoms of allergies can also appear.
Source Outlook
Based on source, the protease market is segmented into plants, animals, and microbes. The plant segment acquired a substantial revenue share in the protease market in 2021. Papain and bromelain are two examples of the category of proteases that are derived from plants. Also, factors such as climatic, viability, culture, circumstances, and drawn-out extraction procedures have a significant impact on the usage of plants as a source of proteases. Thus, the protease market would grow in this segment over the forecast period.
Application Outlook
On the basis of application, the protease market is fragmented into food & beverage, pharmaceuticals, animal feed, soap & detergent and others. The soap & detergent segment held the largest revenue share in the protease market in 2021. Protease's ability to remove stains has made it possible to use it in detergent manufacturing. Consumer awareness of hygiene and cleanliness is predicted to increase, which will increase the demand for soaps and detergents.
Regional Outlook
Region wise, the protease market is analyzed across the North America, Europe, Asia Pacific and LAMEA. The North America region led the protease market with maximum revenue share in 2021. The rising demand for both plant- and animal-based proteases is responsible for the expansion of the regional protease market. The demand for protease is further derived from a variety of food functionalities, the growing importance of washing goods, the rising need for infant formula, and expanding consumption as well as production of meat products.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Advanced Enzyme Technologies Limited, Amano Enzyme, Inc., Associated British Foods PLC, BASF SE, Dupont De Nemours, Inc., Koninklijke DSM N.V., Novozymes A/S, Chr. Hansen Holding A/S, Biocatalysts Limited (Brain AG), and Dyadic International, Inc.
Strategies deployed in Protease Market
Nov-2021: Biocatalysts introduced Promod 324L, a new enzyme added to their range of enzymes for the pet food industry. The Promod 324L offers a broad substrate specificity and high effectiveness in the hydrolysis of both animal & fish protein. Promod 324 would be developed specifically with an exceptional blend of endopeptidase activities for the hydrolysis of animal waste protein.
Jun-2021: Novozymes Feed Enzymes Alliance launched ProAct 360, the company's breakthrough second-generation protease. ProAct 360 would deliver more consistent enhancements in growth performance, along with advanced matrix values for key amino acids & faster action.
Mar-2021: Amano Enzyme released Umamizyme Pulse; a non-GMO enzyme designed for use in a variety of plant protein products. Umamizyme Pulse would work well in an acidic environment, enabling the customers to prevent contamination with less salt.
Feb-2021: Novozymes came into partnership with FMC, an American chemical manufacturing company. This partnership would support Novozymes' existing BioAg base in microbes. Under this partnership, both companies would co-develop enzyme solutions for two segments, leveraging Novozymes' multi-partner setup in BioAg. In addition, this would leverage Novozymes' enzyme biocontrol technology development to date, and the companies would work together to grab growth opportunities and seek the necessary approvals to commercialize the technology in the relevant markets.
Dec-2020: DuPont Nutrition & Biosciences released Versilk, the latest in its range of enzymes. This launch would help yogurt & beverage producers achieve optimal texture & taste in yogurts, drinkable dairy products, and other drinkable fermented products.
Oct-2020: BASF expanded its existing protease portfolio by adding Lavergy Pro 106 LS, and Lavergy Pro 114 LS. This expansion enhances BASF's enzyme portfolio with a novel stabilizing protease making formulation development even more sustainable. Further, this expansion aimed at strengthening the emerging market for enzymes with BASF's excellent innovation pipeline & high-quality standards to improve the development of effective and sustainable solutions together with the consumers.
Jul-2020: Royal DSM formed a joint venture, Olatein, with Avril, France's fourth-largest agro-industrial group. Through this joint venture, the DSM and Avril would together develop CanolaPRO, a high-quality and nutritious protein that supports the DSM's consumers to provide them with better tasting, more enjoyable meat and dairy alternatives in line with the market trends.
Mar-2019: DuPont Nutrition & Biosciences released OPTIMASE, the latest portfolio of biobased enzymes for medical instrument cleaning applications. OPTIMASE offers a better, more efficient & cleaner biobased alternative for detergent manufacturers that serve the medical instrument cleaning industry.
Mar-2019: BASF unveiled Natuphos E, a new generation phytase. Natuphos E would enable poultry to better use nutrients like phosphorous, amino acids, calcium, and energy. The new enzyme would promote healthy growth in animals as well as reduces phosphorus emissions from livestock.
Market Segments covered in the Report:
By Application
By Source
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures